Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mônica M Bastos

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Topics in Medicinal Chemistry|October 12, 2013
Fluorinated compounds against Mycobacterium tuberculosisNúbia Boechat, Mônica M Bastos
European Journal of Medicinal Chemistry|December 29, 2015
Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistryMônica M Bastos, Carolina C P Costa, Talitha C Bezerra, et al.
Thescientificworldjournal|December 7, 2013
Evaluation of genotoxic effects of new molecules with possible trypanocidal activity for Chagas disease treatmentFrancisco V C Mello, Alcione S Carvalho, Mônica M Bastos, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 30, 2007
Design, synthesis and pharmacological evaluation of HIV-1 reverse transcriptase inhibition of new indolin-2-onesNúbia Boechat, W Bruce Kover, Vera Bongertz, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2016
New pentasubstituted pyrrole hybrid atorvastatin-quinoline derivatives with antiplasmodial activityRita C C Carvalho, Wagner A Martins, Tayara P Silva, et al.
Antimicrobial Agents and Chemotherapy|November 21, 2018
Beyond Members of the <i>Flaviviridae</i> Family, Sofosbuvir Also Inhibits Chikungunya Virus ReplicationAndré C Ferreira, Patrícia A Reis, Caroline S de Freitas, et al.
Plos Neglected Tropical Diseases|January 31, 2019
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivoCaroline S de Freitas, Luiza M Higa, Carolina Q Sacramento, et al.
Scientific Reports|January 19, 2017
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replicationCarolina Q Sacramento, Gabrielle R de Melo, Caroline S de Freitas, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Topics in Medicinal Chemistry|October 12, 2013
Fluorinated compounds against Mycobacterium tuberculosisNúbia Boechat, Mônica M Bastos
European Journal of Medicinal Chemistry|December 29, 2015
Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistryMônica M Bastos, Carolina C P Costa, Talitha C Bezerra, et al.
Thescientificworldjournal|December 7, 2013
Evaluation of genotoxic effects of new molecules with possible trypanocidal activity for Chagas disease treatmentFrancisco V C Mello, Alcione S Carvalho, Mônica M Bastos, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 30, 2007
Design, synthesis and pharmacological evaluation of HIV-1 reverse transcriptase inhibition of new indolin-2-onesNúbia Boechat, W Bruce Kover, Vera Bongertz, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2016
New pentasubstituted pyrrole hybrid atorvastatin-quinoline derivatives with antiplasmodial activityRita C C Carvalho, Wagner A Martins, Tayara P Silva, et al.
Antimicrobial Agents and Chemotherapy|November 21, 2018
Beyond Members of the <i>Flaviviridae</i> Family, Sofosbuvir Also Inhibits Chikungunya Virus ReplicationAndré C Ferreira, Patrícia A Reis, Caroline S de Freitas, et al.
Plos Neglected Tropical Diseases|January 31, 2019
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivoCaroline S de Freitas, Luiza M Higa, Carolina Q Sacramento, et al.
Scientific Reports|January 19, 2017
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replicationCarolina Q Sacramento, Gabrielle R de Melo, Caroline S de Freitas, et al.
Pageof 1